Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
FOR IMMEDIATE RELEASE / Phoenix, March 02, 2018 -- / BioNovelus, Inc. (ONOV), whose CR-10® Biofungicide is a non-toxic solution for safe and effective pre- and post-harvest applications, is announcing effective immediately, that Anthony Parkinson, Chief Information Officer, is no longer employed with BioNovelus. We wish him well in his new endeavor. Also, Mr. Parkinson has resigned from his board seat, effective immediately.
There is no replacement currently for his position. A search for a new C.I.O. will begin in the weeks to come.
Please send any correspondence or questions to [email protected]
BioNovelus is part of the award-winning business incubator program at the Center for Entrepreneurial Innovation in Phoenix, Arizona.
Media contact: Nathalie Ekobo, Marketing & Communications Director BioNovelus, Inc. +1 888-924-6668 ext.0 [email protected]
